Suppr超能文献

Barts 健康国民保健信托 COVID-19 队列:伦敦东部患者的特征、结局和风险评分。

The Barts Health NHS Trust COVID-19 cohort: characteristics, outcomes and risk scoring of patients in East London.

机构信息

The Royal London Hospital, Barts Health NHS Trust, Whitechapel, London, UK.

Wolfson Institute of Preventive Medicine, Queen Mary University of London, Mile End Road, London, UK.

出版信息

Int J Tuberc Lung Dis. 2021 May 1;25(5):358-366. doi: 10.5588/ijtld.20.0926.

Abstract

Barts Health National Health Service Trust (BHNHST) serves a diverse population of 2.5 million people in London, UK. We undertook a health services assessment of factors used to evaluate the risk of severe acute respiratory coronavirus 2 (SARS-CoV-2) infection. Patients with confirmed polymerase chain reaction (PCR) test results admitted between 1 March and 1 August 2020 were included, alongwith clinician-diagnosed suspected cases. Prognostic factors from the 4C Mortality score and 4C Deterioration scores were extracted from electronic health records and logistic regression was used to quantify the strength of association with 28-day mortality and clinical deterioration using national death registry linkage. Of 2783 patients, 1621 had a confirmed diagnosis, of whom 61% were male and 54% were from Black and Minority Ethnic groups; 26% died within 28 days of admission. Mortality was strongly associated with older age. The 4C mortality score had good stratification of risk with a calibration slope of 1.14 (95% CI 1.01-1.27). It may have under-estimated mortality risk in those with a high respiratory rate or requiring oxygen. Patients in this diverse patient cohort had similar mortality associated with prognostic factors to the 4C score derivation sample, but survival might be poorer in those with respiratory failure.

摘要

巴茨健康国民保健信托(BHNHST)为英国伦敦 250 万人口提供服务。我们对用于评估严重急性呼吸冠状病毒 2(SARS-CoV-2)感染风险的因素进行了卫生服务评估。研究纳入了 2020 年 3 月 1 日至 8 月 1 日期间经聚合酶链反应(PCR)检测确诊的患者,以及临床诊断为疑似病例的患者。从 4C 死亡率评分和 4C 恶化评分中提取预后因素,使用电子健康记录,并通过逻辑回归来量化与 28 天死亡率和临床恶化的关联强度,使用国家死亡登记处进行链接。在 2783 名患者中,有 1621 名患者的诊断得到了确认,其中 61%为男性,54%为黑人或少数族裔;26%的患者在入院后 28 天内死亡。死亡率与年龄较大密切相关。4C 死亡率评分具有良好的风险分层能力,校准斜率为 1.14(95%CI 1.01-1.27)。它可能低估了呼吸急促或需要吸氧患者的死亡率风险。在这个多样化的患者队列中,与预后因素相关的死亡率与 4C 评分推导样本相似,但在呼吸衰竭患者中,生存率可能较低。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验